Replies to post #184052 on Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

Looking at the big picture chemo resistant Ovarian tumors is a excellent start . Phase 1 reported as a secondary endpoint that even in it's present short half life a therapeutic effect against stage 4 ovarian cancer was seen.

August13 2016
“This will be a small trial that will move quickly with the end goal to provide the critical data necessary to forge a partnership with a large pharmaceutical company interested in co-developing Kevetrin as it makes progress toward possibly becoming the first p53-activating drug approved by the FDA.”